{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:09:28Z","timestamp":1722888568799},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[1996,8,1]],"date-time":"1996-08-01T00:00:00Z","timestamp":838857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[1996,8]]},"DOI":"10.1007\/bf01957144","type":"journal-article","created":{"date-parts":[[2005,8,2]],"date-time":"2005-08-02T05:04:43Z","timestamp":1122959083000},"page":"640-648","source":"Crossref","is-referenced-by-count":4,"title":["Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood \u2014 follow up after 9 years"],"prefix":"10.1007","volume":"155","author":[{"given":"G. E.","family":"Janka-Schaub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Graubner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gutjahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Juergens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. J.","family":"Spaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Coall Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01957144_CR1","first-page":"1419","volume":"61","author":"WA Bleyer","year":"1977","unstructured":"Bleyer, WA (1977) Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics. Cancer Treat Rep 61:1419\u20131425","journal-title":"Cancer Treat Rep"},{"issue":"Suppl 2","key":"BF01957144_CR2","first-page":"151","volume":"23","author":"RL Capizzi","year":"1974","unstructured":"Capizzi, RL (1974) Schedule-dependent synergism and antagonism between methotrexate and asparaginase. Biochem Pharmacol 23 [Suppl 2]:151\u2013161","journal-title":"Biochem Pharmacol"},{"issue":"Suppl 2","key":"BF01957144_CR3","first-page":"157","volume":"6","author":"JM Chessels","year":"1992","unstructured":"Chessels JM, Bailey CC, Richards S on behalf of the Medical Research Council Working Party on Childhood Leukaemia (1992) MRC UKALL X. The UK protocol for childhood ALL: 1985\u20131990. Leukemia 6 [Suppl 2]: 157\u2013161","journal-title":"Leukemia"},{"key":"BF01957144_CR4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM198609113151101","volume":"315","author":"LA Clavell","year":"1986","unstructured":"Clavell LA, Gelber, RD, Cohen HJ, Hitchcock-Bryan S, Cassady JR, Tarbell NJ, Blattner SR, Tantravahi R, Leavitt P, Sallan SE (1986) Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med 315:657\u2013663","journal-title":"N Engl J Med"},{"key":"BF01957144_CR5","first-page":"2109","volume":"51","author":"VT Vita De","year":"1983","unstructured":"De Vita VT (1983) The relationship between tumor mass and resistance to chemotherapy. Cancer 51:2109","journal-title":"Cancer"},{"key":"BF01957144_CR6","first-page":"352","volume":"206","author":"U Drescher","year":"1994","unstructured":"Drescher U, Stehn M, Harms D, Kapaun P, Goertitz I, Kohlschuetter A, Janka-Schaub GE (1994) Differing length of asparagine depletion in children receiving treatment withE. coli (C-ASP)-orErwinia-asparaginase (E-ASP) (abstract). Klin Paediatr 206: 352","journal-title":"Klin Paediatr"},{"key":"BF01957144_CR7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-2007-1025353","volume":"204","author":"O Gobrecht","year":"1992","unstructured":"Gobrecht O, Goebel U, Graubner U, Gutjahr P, Schoeck V, Spaar HJ, Janka-Schaub GE fuer die COALL-Studiengruppe (1992) Einflu\u00df von Dosisintensitaet und therapiebedinger Leukozytopenie in der Intensivtherapie auf die Prognose bei akuter lymphatischer Leukaemie im Kindesalter. Klin Paediatr 204:230\u2013235","journal-title":"Klin Paediatr"},{"key":"BF01957144_CR8","first-page":"1727","volume":"63","author":"JH Goldie","year":"1979","unstructured":"Goldie JH, Coldman AJ (1979) A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63:1727\u20131733","journal-title":"Cancer Treat Rep"},{"key":"BF01957144_CR9","first-page":"439","volume":"66","author":"JH Goldie","year":"1982","unstructured":"Goldie JH, Coldman AJ, Gudauskas GA (1982) Rationale for the use of altermating non-cross-resistant chemotherapy. Cancer Treat Rep 66:439\u2013449","journal-title":"Cancer Treat Rep"},{"key":"BF01957144_CR10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1651-2227.1987.tb10565.x","volume":"76","author":"G Gustafsson","year":"1987","unstructured":"Gustafsson G, Garwicz S, Hertz H, Johanesson G, Jonmundsson G, Moe PJ, Salmi T, Seip M, Siimes MA, Yssing M, Ahstroem L (1987) A populationbased study of childhood acute lymphoblastic leukemia diagnosed from July 1981 through June 1985 in the five nordic countries. Acta Paediatr Scand 76:781\u2013788","journal-title":"Acta Paediatr Scand"},{"key":"BF01957144_CR11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/1097-0142(19800715)46:2<241::AID-CNCR2820460203>3.0.CO;2-E","volume":"46","author":"M Haghbin","year":"1980","unstructured":"Haghbin M, Murphy L, Lan CC, Clarkson BD, Thaler HT, Passe S, Burchenal J (1980) A long-term clinical follow-up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens. Cancer 46:241\u2013252","journal-title":"Cancer"},{"key":"BF01957144_CR12","first-page":"197","volume":"23","author":"D Harms","year":"1994","unstructured":"Harms D, Schwamborn D, Spaar HJ, Graubner U, Schoeck V, Winkler K, Janka GE for the COALL Study Group (1994) Daunorubicin-induced cell kill with 1-hour vs. 24-hour infusions: randomized comparison in newly diagnosed children with acute lymphoblastic leukemia. (abstract). Med Pediatr Oncol 23:197","journal-title":"Med Pediatr Oncol"},{"key":"BF01957144_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2008-1034450","volume":"193","author":"G Henze","year":"1981","unstructured":"Henze G, Langermann HJ, Gadner H, Schellong G, Welte K, Riehm H (1981) Ergebnisse der Studie BFM 76\/79 zur Behandlung der akuten lymphoblastischen Leukaemie bei Kindern und Jugendlichen. Klin Paediatr 193: 145\u2013154","journal-title":"Klin Paediatr"},{"key":"BF01957144_CR14","first-page":"65","volume":"14","author":"WM Hryniuk","year":"1987","unstructured":"Hryniuk WM (1987) Average relative dose intensity and the impact on design of clinical trials. Semin Oncol 14:65\u201374","journal-title":"Semin Oncol"},{"issue":"Suppl","key":"BF01957144_CR15","first-page":"73S","volume":"2","author":"GE Janka-Schaub","year":"1988","unstructured":"Janka-Schaub GE, Winkler K, Goebel U, Graubner U, Gutjahr P, Haas RJ, Juergens H, Spaar J for the COALL Study Group (1988) Rapidly rotating combination chemotherapy in childhood acute lymphoblastic leukemia: preliminary results of a randomized comparison with conventional treatment. Leukemia 2 [Suppl]:73S-78S","journal-title":"Leukemia"},{"key":"BF01957144_CR16","first-page":"489","volume":"33","author":"GE Janka-Schaub","year":"1990","unstructured":"Janka-Schaub GE, Goebel U, Graubner U, Haas RJ, Juergens H, Spaar HJ, Winkler K (1990) Improved prognosis for chihdhood acute lymphocytic leukemia with very high white blood cell count (>100\/nl) with rotation of non-cross-resistant drug combinations. Haematol Bloodtransfus 33:489\u2013493","journal-title":"Haematol Bloodtransfus"},{"key":"BF01957144_CR17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-2007-1025434","volume":"203","author":"GE Janka-Schaub","year":"1991","unstructured":"Janka-Schaub GE, Stuehrk H, Kortuem B, Graubner U, Juergens H, Spaar HJ, Schoeck V, Dohrn B, Bahr R, Winkler K fuer die COALL-Studiengruppe (1991) Initiales Ansprechen auf die Therapie als wichtigster prognostischer Faktor bei der akuten lymphoblastischen Leukaemie im Kindesalter. Klin Paediatr 203:231\u2013235","journal-title":"Klin Paediatr"},{"key":"BF01957144_CR18","first-page":"338","volume":"34","author":"H Juergens","year":"1992","unstructured":"Juergens H, Janka G, Ibrahim M, Tonert C, Winkler K, Goebel U (1992) Prognostic significance of exposure to intermediate-dose methotrexate in children with standard risk ALL: the COALL 82\/85 experience. Haematol Bloodtransfus 34:338\u2013352","journal-title":"Haematol Bloodtransfus"},{"key":"BF01957144_CR19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"BF01957144_CR20","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1200\/JCO.1994.12.9.1939","volume":"12","author":"VJ Land","year":"1994","unstructured":"Land VJ, Shuster JJ, Crist WM, Ravindranath Y, Harris MB, Krance RA, Pinkel D, Pullen DJ (1994) Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: A Pediatric Oncology Group Study. J Clin Oncol 12:1939\u20131945","journal-title":"J Clin Oncol"},{"key":"BF01957144_CR21","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/1097-0142(19930501)71:9<2854::AID-CNCR2820710929>3.0.CO;2-J","volume":"71","author":"SJ Lauer","year":"1993","unstructured":"Lauer SJ, Camitta BM, Leventhal BG, Mahoney DH Jr, Shuster JJ, Adair S, Casper JT, Civin CI, Graham M, Kiefer G, Pullen J, Steuber CP, Kamen B (1993) Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. Cancer 71:2854\u20132861","journal-title":"Cancer"},{"key":"BF01957144_CR22","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM199103213241205","volume":"324","author":"SE Lipshultz","year":"1991","unstructured":"Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP (1991) Late cardiac effects of doxorubicin in childhood lymphoblastic leukemia. N Engl J Med 324:808\u2013815","journal-title":"N Engl J Med"},{"key":"BF01957144_CR23","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(81)91216-2","volume":"II","author":"AT Meadows","year":"1981","unstructured":"Meadows AT, Gordon J, Massari DJ, Littman P, Fergusson J, Moss K (1981) Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation. Lancet II:1015\u20131018","journal-title":"Lancet"},{"key":"BF01957144_CR24","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1200\/JCO.1989.7.12.1807","volume":"7","author":"DR Miller","year":"1989","unstructured":"Miller DR, Coccia PF, Bleyer WA, Lukens JN, Siegel SE, Sather HN, Hammond GD (1989) Earty response to induction therapy as a predictor of disease-free survival and late recurence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. J Clin Oncol 7: 1807\u20131815","journal-title":"J Clin Oncol"},{"key":"BF01957144_CR25","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199111073251902","volume":"325","author":"JP Neglia","year":"1991","unstructured":"Neglia JP, Meadows AT, Robison LL, Kim TH, Newton WA, Ruymann FB, Sather HN, Hammond GD (1991) Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 325:1330\u20131336","journal-title":"N Engl J Med"},{"key":"BF01957144_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R Peto","year":"1977","unstructured":"Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trial requiring prolonged observation of each patient. Br J Cancer 35:1\u201339","journal-title":"Br J Cancer"},{"key":"BF01957144_CR27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-2008-1026781","volume":"199","author":"H Riehm","year":"1986","unstructured":"Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein V, Ludwig R, Ritter J, Stollmann B, Henze G (1986) Die Corticosteroidabhaengige Dezimierung der Leukaemiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukaemie im Kindesalter (Therapiestudie ALL-BFM 83). Klin Paediatr 199:151\u2013160","journal-title":"Klin Paediatr"},{"key":"BF01957144_CR28","first-page":"439","volume":"33","author":"H Riehm","year":"1990","unstructured":"Riehm H, Gadner H, Henze G, Komhuber B, Lampert F, Niethammer D, Reiter A, Schellong G (1990) Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematol Bloodtransfus 33: 439\u2013450","journal-title":"Haematol Bloodtransfus"},{"key":"BF01957144_CR29","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/1097-0142(19800315)45:6<1284::AID-CNCR2820450604>3.0.CO;2-Q","volume":"45","author":"GK Rivera","year":"1980","unstructured":"Rivera GK, Aur RJ, Dahl GV, Pratt CB, Wood A, Avery TL (1980) Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia. Cancer 45: 1284\u20131288","journal-title":"Cancer"},{"key":"BF01957144_CR30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0140-6736(91)90733-6","volume":"337","author":"GK Rivera","year":"1991","unstructured":"Rivera GK, Raimondi SC, Hancock ML, Behm FG, Pui CH, Abromowitch M, Mirro J Jr, Ochs JS, Look AT, Williams DL, Murphy SB, Dahl GV, Kalwinsky DK, Evans WE, Kun LE, Simone JV, Crist WM (1991) Improved outcome in childhood acute lymhoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet 337:61\u201366","journal-title":"Lancet"},{"key":"BF01957144_CR31","first-page":"425","volume":"51","author":"SE Sallan","year":"1978","unstructured":"Sallan SE, Camitta BM, Cassady JR, Nathan DG, Frei E III (1978) Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results. Blood 51:425\u2013433","journal-title":"Blood"},{"key":"BF01957144_CR32","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1200\/JCO.1994.12.4.740","volume":"12","author":"MA Schorin","year":"1994","unstructured":"Schorin MA, Blattner S, Gelber RD, Tarbell NJ, Donnelly M, Dalton V, Cohen HJ, Sallan SE (1994) Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute\/Children's Hospital acute lymphoblastic leukemia consortium protocol 85\u201301. J Clin Oncol 12:740\u2013747","journal-title":"J Clin Oncol"},{"key":"BF01957144_CR33","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1200\/JCO.1986.4.5.744","volume":"4","author":"PG Steinherz","year":"1986","unstructured":"Steinherz PG, Gaynon P, Miller DR, Reaman G, Bleyer A, Finklestein J, Evans RG, Meyers P, Steinherz LJ, Sather H, Hammond D (1986) Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen \u2014 a new intensive therapy protocol: A report form the Childrens Cancer Study Group. J Clin Oncol 4:744\u2013752","journal-title":"J Clin Oncol"},{"key":"BF01957144_CR34","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1200\/JCO.1985.3.7.998","volume":"3","author":"RJ Wells","year":"1985","unstructured":"Wells RJ, Feusner J, Devney R, Woods WG, Provisor AJ, Cairo MS, Odom LF Nachman J, Jones GR, Ettinger LJ, Capizzi RL (1985) Sequential highdose cytosine arbinoside-asparaginase treatment in advanced childhood leukemia. J Clin Oncol 3:998\u20131004","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01957144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01957144\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01957144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T17:28:16Z","timestamp":1557768496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01957144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1996,8]]}},"alternative-id":["BF01957144"],"URL":"https:\/\/doi.org\/10.1007\/bf01957144","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"type":"print","value":"0340-6199"},{"type":"electronic","value":"1432-1076"}],"subject":[],"published":{"date-parts":[[1996,8]]}}}